Track topics on Twitter Track topics that are important to you
GW Pharmaceuticals, a British biotech developing cannabinoid drugs, is on a high after a successful €300M public offering on the Nasdaq Stock Market. The company announced the public offering swiftly after its lead cannabinoid drug, Epidiolex, made history by being ...
The post Cannabinoid Drugs Company Raises €300M in Public Offering appeared first on Labiotech.eu.
Original Article: Cannabinoid Drugs Company Raises €300M in Public OfferingNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...